[1]
Pimenta, R., Costa-Rosa, J., Cravo, M., Rafael, M. and Moura, C. 2021. Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma. Journal of the Portuguese Society of Dermatology and Venereology. 79, 1 (Apr. 2021), 11-20. DOI:https://doi.org/10.29021/spdv.79.1.1288.